Gestrinone showed no clear difference in side effects: acne compared with danazol (low certainty).
Gestrinone may leads to lower amenorrhoea compared with leuprolin (low certainty).
Gestrinone may leads to higher spotting or bleeding compared with leuprolin (low certainty).
Gestrinone may leads to lower side effects: hot flushes compared with leuprolin (low certainty).
It is very uncertain whether gestrinone changes pelvic pain: none or mild compared with danazol (very low certainty).
It is very uncertain whether gestrinone changes dysmenorrhoea: none or mild compared with danazol (very low certainty).
It is very uncertain whether gestrinone changes dyspareunia: none or mild compared with danazol (very low certainty).
It is very uncertain whether gestrinone changes side effects: hirsutism compared with danazol (very low certainty).
Gestrinone may leads to lower decreased breast size compared with danazol (low certainty).
Fluoroquinolone substitution for isoniazid in a standard six month… showed no clear difference in death from any cause compared with standard regimen (low certainty).
Fluoroquinolone substitution for isoniazid in a standard six month… showed no clear difference in TB‐related death compared with standard regimen (low certainty).
Fluoroquinolone substitution for isoniazid in a standard six month… showed no clear difference in sputum culture conversion at 8 weeks compared with standard regimen (low certainty).
Fluoroquinolone substitution for isoniazid in a standard six month… showed no clear difference in serious adverse events compared with standard regimen (low certainty).
It is very uncertain whether fluoroquinolone substitution for ethambutol in a standard six month… changes death from any cause compared with standard regimen (very low certainty).
It is very uncertain whether fluoroquinolone substitution for ethambutol in a standard six month… changes TB‐related death compared with standard regimen (very low certainty).